These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27206322)

  • 41. Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis.
    Germano V; Picchianti Diamanti A; Baccano G; Natale E; Onetti Muda A; Priori R; Valesini G
    Ann Rheum Dis; 2005 Oct; 64(10):1519-20. PubMed ID: 16162908
    [No Abstract]   [Full Text] [Related]  

  • 42. [Update in treatment of psoriatic arthritis].
    Abdelmoula LC; Ben M'Barek R; Yahia CB; Tekaya R; Testouri N; Chaabouni L; Zouari R
    Tunis Med; 2008 Dec; 86(12):1036-41. PubMed ID: 19213510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optic neuritis in a psoriatic arthritis patient treated by infliximab.
    Minami-Hori M; Tsuji H; Takahashi H; Hanada K; Iizuka H
    J Dermatol; 2013 Apr; 40(4):298-9. PubMed ID: 23289758
    [No Abstract]   [Full Text] [Related]  

  • 44. Application and modifications of minimal disease activity measures for patients with psoriatic arthritis treated with adalimumab: subanalyses of ADEPT.
    Mease PJ; Heckaman M; Kary S; Kupper H
    J Rheumatol; 2013 May; 40(5):647-52. PubMed ID: 23504383
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of severe psoriasis and psoriatic arthritis with adalimumab in an HIV-positive patient.
    Lindsey SF; Weiss J; Lee ES; Romanelli P
    J Drugs Dermatol; 2014 Jul; 13(7):869-71. PubMed ID: 25007373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pancytopenia in a patient with psoriatic arthritis treated with methotrexate and concomitant lithium.
    Maharaj AB; Chandran V
    J Rheumatol; 2015 Mar; 42(3):557. PubMed ID: 25729049
    [No Abstract]   [Full Text] [Related]  

  • 47. Psoriatic arthritis.
    Durham LE; Taams LS; Kirkham BW
    Br J Hosp Med (Lond); 2016 Jul; 77(7):C102-8. PubMed ID: 27388392
    [No Abstract]   [Full Text] [Related]  

  • 48. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adalimumab-Induced Disseminated Superficial Porokeratosis.
    Guarneri C; Cannavò SP; Lentini M; Polimeni G
    Ann Pharmacother; 2011 Feb; 45(2):280-1. PubMed ID: 21304021
    [No Abstract]   [Full Text] [Related]  

  • 50. Adalimumab-associated Acquired Hemophilia in a Patient with Scleritis.
    Liberman P; Burkholder BM
    Ocul Immunol Inflamm; 2022 Feb; 30(2):294-296. PubMed ID: 32966141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis.
    Bergman M; Lundholm A
    Arthritis Res Ther; 2017 Mar; 19(1):63. PubMed ID: 28320454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral tuberculoma with pulmonary tuberculosis in a patient with psoriasis treated with adalimumab, an anti-tumor necrosis factor-α agent.
    Selvarajah L; Choon SE; Tarekh NA; Chhetri AD
    Int J Dermatol; 2016 Feb; 55(2):e115-7. PubMed ID: 26566776
    [No Abstract]   [Full Text] [Related]  

  • 53. Serious pancytopenia from methotrexate treatment of psoriatic arthritis.
    Chang YC; Chen JD; Yen DH; Wang LM; Huang CI; Lee CH
    Am J Emerg Med; 2006 May; 24(3):392-4. PubMed ID: 16635735
    [No Abstract]   [Full Text] [Related]  

  • 54. Transient and slight thrombocytopaenia induced by etanercept during treatment of psoriatic arthritis.
    Stinco G; Piccirillo F; Patrone P
    Acta Derm Venereol; 2008; 88(3):281-2. PubMed ID: 18480934
    [No Abstract]   [Full Text] [Related]  

  • 55. Ultrasound-integrated tight control in early psoriatic arthritis during adalimumab treatment.
    Bandinelli F; Bonacci E; Matucci-Cerinic M
    Clin Exp Rheumatol; 2013; 31(3):440-2. PubMed ID: 23582466
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lichenoid drug eruption caused by adalimumab: a case report and literature review.
    Inoue A; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
    Eur J Dermatol; 2017 Feb; 27(1):69-70. PubMed ID: 27777187
    [No Abstract]   [Full Text] [Related]  

  • 57. Responses to adalimumab in patients with active psoriatic arthritis who have not adequately responded to prior therapy: effectiveness and safety results from an open-label study.
    Gladman DD; ; Sampalis JS; Illouz O; Guérette B
    J Rheumatol; 2010 Sep; 37(9):1898-906. PubMed ID: 20595284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapidly fatal pulmonary fibrosis in a patient with psoriatic arthritis treated with adalimumab.
    Cohen JV; Capell BC; Kinniry PA; Epstein AL
    J Rheumatol; 2011 Feb; 38(2):398-9. PubMed ID: 21285183
    [No Abstract]   [Full Text] [Related]  

  • 59. Infliximab treatment in psoriatic arthritis: our experience.
    Rioda WT; Adorni G
    Acta Biomed; 2006 Aug; 77(2):95-102. PubMed ID: 17172189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Biological agents in treatment of psoriatic arthritis].
    Lewicki M; Dutkiewicz B; Widuchowska M; Kucharz EJ
    Pol Merkur Lekarski; 2008 Jul; 25(145):97-100. PubMed ID: 18839626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.